iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Stock Price Down 0% – Time to Sell?

iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) traded down 0% on Tuesday . The company traded as low as $83.47 and last traded at $84.14. 22,915 shares traded hands during trading, a decline of 76% from the average session volume of 95,904 shares. The stock had previously closed at $84.17.

iShares U.S. Pharmaceuticals ETF Stock Performance

The firm has a market capitalization of $942.37 million, a price-to-earnings ratio of 17.75 and a beta of 0.54. The business has a 50 day simple moving average of $88.16 and a 200-day simple moving average of $82.09.

Institutional Investors Weigh In On iShares U.S. Pharmaceuticals ETF

Hedge funds and other institutional investors have recently bought and sold shares of the company. Mather Group LLC. purchased a new position in iShares U.S. Pharmaceuticals ETF during the third quarter worth about $38,000. EFG International AG acquired a new position in iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at about $38,000. Assetmark Inc. boosted its holdings in iShares U.S. Pharmaceuticals ETF by 203.9% in the 4th quarter. Assetmark Inc. now owns 465 shares of the company’s stock valued at $39,000 after purchasing an additional 312 shares during the last quarter. O Shaughnessy Asset Management LLC grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 35.0% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock valued at $39,000 after buying an additional 120 shares during the period. Finally, Blueline Advisors LLC purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at approximately $41,000.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.